Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex aged >18 years Patients willing to sign the informed consent form Patients with significant coronary artery stenosis (diameter stenosis >70% based on visual assessment on the coronary angiogram) in at least one native coronary artery after angiography
Exclusion criteria
Exclusion criteria: Patients unwilling to sign the informed consent Patients with hypotension, shock or need for mechanical support or intravenous vasopressors Patients with extreme angulation ( >90â?°), or excessive vessel tortuosity Patients with renal insufficiency (estimated glomerular filtration rate Patients with contraindications to dual antiplatelet therapy up to 1 year Patients with other comorbidities that may limit life expectancy to less than one year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in procedural strategy pre- and post PCI with ACR (Pre-PCI strategy change involves change in the intended stent length and size, and intended device landing zone; and post-PCI strategy change involves the intended need for additional interventional procedures for PCI optimization after identification of stent malapposition, edge dissections, and stent under expansion.Timepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedural outcomes with ACR-guided PCI in the entire study population Procedural outcomes with ACR-guided PCI in the sub-set of patients with complex coronary artery lesions, such as diffusely diseased vessel segments, or segments with missing anatomical landmarks Rate of MACE at 6 monthsâ?? and 1-year with ACR-guided PCI (death, myocardial infarction, target vessel revascularization [TVR] or target lesion revascularization [TLR])Timepoint: 12 months | — |
Countries
India
Contacts
Lisie hospital